Compound News and Research

RSS

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals announced today that Eli Lilly and Company licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development.

20 Sep 2004

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

If future studies show their test -- measuring the level of activity of a signaling pathway called Hedgehog -- can predict which prostate cancers will spread, the results could revolutionize decision making processes for prostate cancer patients, the researchers say.

13 Sep 2004

Health problems among timber workers exposed to industry chemical PCP are to be investigated

The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.

13 Sep 2004

Cancer drug may reduce kidney disease in lupus

A drug that is already being tested as an anticancer agent, especially in lymphoma, may also reduce the kidney disease that is a result of systemic lupus, according to a researcher at Wake Forest University Baptist Medical Center.

10 Sep 2004

Findings about diabetic eye disease may lead to improved screenings and treatment for people with diabetes

Eli Lilly and Company have announced key findings from analyses of prior study data that enhances understanding of vision loss due to diabetic retinopathy, a diabetic microvascular complication that affects an estimated 50 million people worldwide.

10 Sep 2004

Broccoli, cauliflower and cabbage effective in disrupting late stages of cell growth in breast cancer

A well known anti-cancer agent in certain vegetables has just had its reputation enhanced. The compound, in broccoli and other cruciferous vegetables, has been found to be effective in disrupting late stages of cell growth in breast cancer.

1 Sep 2004

Alcohol in moderation maintains a healthy heart and reduces tissue damage following a heart attack

For years researchers have tried to determine why the French have such a lower rate of cardiovascular disease, given the amount of fat consumed in their diets.

30 Aug 2004

Solid evidence that best treatment for multiple sclerosis is pregnancy

For years, doctors have suggested the best treatment for multiple sclerosis is pregnancy. Now, an Oregon study is delivering solid evidence to support the theory.

27 Aug 2004

FDA approves revised labeling for anti-inflammatory corticosteroid nasal spray

AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).

26 Aug 2004

New class of compounds play a role in protecting the cardiovascular system

Half a million Americans are diagnosed each year with heart failure, a progressively debilitating condition characterized by the heart's declining ability to pump blood efficiently.

25 Aug 2004

Blueberries may lower cholesterol

New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.

23 Aug 2004

New information about how HIV evades eradication from the body

Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.

23 Aug 2004

Nitroxyl-releasing drugs promise to revive failing hearts

Half a million Americans are diagnosed each year with heart failure, a progressively debilitating condition characterized by the heart's declining ability to pump blood efficiently.

22 Aug 2004

Dual-action compound shows promise in killing prostate cancer cells

Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.

22 Aug 2004

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Thanks to new screening tools, and some luck, researchers at the University of Chicago have discovered three unrelated compounds that inhibit the two toxins – edema factor and lethal factor -- that have made anthrax one of the most feared of potential bioterror agents.

21 Aug 2004

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

A beautiful, but often deadly, snail from the sea has been revealed as a largely untapped source of natural healing powers for a range of illnesses from chronic pain to diseases of the brain.

20 Aug 2004

Synthetic drug nicknamed Oz is set to become the major weapon in the fight against multi-drug resistant malaria

The new synthetic drug nicknamed Oz is set to become the major weapon in the fight against multi-drug resistant malaria and could be available to patients within three years.

20 Aug 2004

Toxic chemical in hand soaps, cleaner is deposited and remains in the environment long after the products are used

A toxic chemical used in hand soaps, cleaners and other personal care products to kill germs is deposited and remains in the environment long after the products are used, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

18 Aug 2004

80% of cancer patients use some form of complementary or alternative therapies

Plug the terms "alternative" and "cancer" into Google and the Internet search engine returns a list of 3.27 million - yes, million - sites with information both credible and questionable about nontraditional treatments for cancer. What's a cancer patient to make of such a vast array of options?

18 Aug 2004

In the fragmented European hospital information systems market, established vendors have a distinct advantage

New vendors are therefore finding it extremely difficult to break through the barriers and reach potential clients. While some cash-rich vendors have attempted to address this issue through the acquisitions route.

18 Aug 2004

Compound News and Research

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

Health problems among timber workers exposed to industry chemical PCP are to be investigated

Cancer drug may reduce kidney disease in lupus

Findings about diabetic eye disease may lead to improved screenings and treatment for people with diabetes

Broccoli, cauliflower and cabbage effective in disrupting late stages of cell growth in breast cancer

Alcohol in moderation maintains a healthy heart and reduces tissue damage following a heart attack

Solid evidence that best treatment for multiple sclerosis is pregnancy

FDA approves revised labeling for anti-inflammatory corticosteroid nasal spray

New class of compounds play a role in protecting the cardiovascular system

Blueberries may lower cholesterol

New information about how HIV evades eradication from the body

Nitroxyl-releasing drugs promise to revive failing hearts

Dual-action compound shows promise in killing prostate cancer cells

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Synthetic drug nicknamed Oz is set to become the major weapon in the fight against multi-drug resistant malaria

Toxic chemical in hand soaps, cleaner is deposited and remains in the environment long after the products are used

80% of cancer patients use some form of complementary or alternative therapies

In the fragmented European hospital information systems market, established vendors have a distinct advantage

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News